(This story has been updated to reflect a British Columbia court’s approval of Ascent’s sale.)
The Supreme Court of British Columbia has approved the sale of financially troubled cannabis firm Ascent Industries for 41.5 million Canadian dollars ($30 million), comprising CA$29 million in cash and the assumption of liabilities totaling some CA$12 million.
The deal is expected to close around April 3.
Ascent had been granted creditor protection in early March to address liquidity issues after its cultivation subsidiary, Agrima Botanicals, was stripped of its license over infractions related to noncompliance.
The British Columbia-based company entered into an asset purchase agreement with Bzam Management, an affiliate of Gulf Bridge, involving all of the assets comprising the Canadian business.
The deal does not include Ascent’s cannabis cultivation, production and distribution assets in Oregon, Nevada and Denmark.
Interim CEO Blair Jordan had told Marijuana Business Daily that the price tag with Bzam would only be be disclosed after the court had approved the purchase agreement.
Health Canada suspended the licenses of at least four cannabis companies since 2014, however Ascent was the first to lose its license outright over noncompliance.
The health agency notified Ontario-based Agrima Botanicals on Sept. 26 that it was suspending the company’s production and dealer licenses over infractions related to noncompliance with the Access to Cannabis for Medical Purposes Regulations and the Narcotic Control Regulations.
The company failed to demonstrate to federal authorities by February that the suspension of its cannabis licenses was unfounded, leading to the license revocation.
Ascent’s stock, which is traded on the Canadian Securities Exchange as ASNT, has fallen 88% since September.
Matt Lamers can be reached at firstname.lastname@example.org